Skip to main content
  • Overview
    • Press Releases
    • Events & Presentations
      • Corporate Presentations
    • Stock Info
      • Stock Quote
      • Stock Chart
      • Form 8937 - Organizational Actions
      • Analyst Coverage
    • Financials
      • Quarterly Reports
      • Annual Reports
      • SEC Filings
    • Governance
    • Resources
      • Investor FAQs
      • Information Request Form
      • Email Alerts
      • Contacts
Skip to main content
Adverum Logo
Site Search
Adverum Logo

Preserving Sightfor Life.®

  • About Us
  • Our Technology
  • Pipeline
  • For Patients & Caregivers
  • Join The Team
  • News, Scientific
    Presentations & Publications
  • Contact Us
  • Investors
    • Our Global Mission
    • Core Values
    • Sustainability
    • Leadership Team
    • Board of Directors
    • Scientific Advisors
    • Board Committees
    • Reimagining Ocular Gene Therapy
    • Therapeutic Protein Biofactories
    • Sustained Protein Expression Efficient
    • Efficient, Scalable Manufacturing
    • Our Programs
    • ADVM-022 / OPTIC
    • Overview
    • Resources
    • Our Commitment
    • Expanded Access Policy
    • Life at Adverum
    • Our Credo
    • Our Benefits
    • Diversity, Equity, and Inclusion
    • Careers
    • In the News
    • Publications
    • Overview
    • Press Releases
    • Events & Presentations
    • Stock Quote & Chart
    • Analyst Coverage
    • SEC Filings
    • Governance
    • Email Alerts
    • Investor FAQ's
We are driven to establish gene therapy as a new standard of care for the leading causes of vision loss.

About Us

Our Technology

Pipeline

For Patients & Caregivers

Investors

Join the Team

News & Publications

Seeing Beyond Blog

Contact Us

@Adverum Biotechnologies, Inc. All rights reserved.
  • Privacy Policy
  • Community Guidelines

ADVERUM

Adverum Biotechnologies, Inc.,
100 Cardinal Way
Redwood City, CA 94063

Tel: 650-656-9323Fax: 650-649-1995